Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 11, Number 6—June 2005

Dispatch

Cephalosporin and Ciprofloxacin Resistance in Salmonella, Taiwan

Jing-Jou Yan*, Chien-Shun Chiou†, Tsai-Ling Yang Lauderdale‡, Shu-Huei Tsai*, and Jiunn-Jong Wu*Comments to Author 
Author affiliations: *National Cheng Kung University College of Medicine, Tainan, Taiwan; †Center for Disease Control, Taichung City, Taiwan; ‡National Health Research Institutes, Taipei, Taiwan

Main Article

Figure 1

EcoRI restriction patterns of transferred CMY-2–encoding plasmids of 18 Salmonella isolates. The result of the hybridization assay with the blaCMY-2 probe labeled with digoxigenin (Roche Molecular Biochemicals, Mannheim, Germany) is shown below the gel, and arrowheads indicate the locations of the restriction fragments that were hybridized. Lanes 2–21, plasmids from transconjugants of Salmonella isolates NB04.022, SB04.003, NL04.050, SA04.028, CG04.039, SG04.039, SG04.042, SE04.006, SG04.047, SE

Figure 1. . EcoRI restriction patterns of transferred CMY-2–encoding plasmids of 18 Salmonella isolates. The result of the hybridization assay with the blaCMY-2 probe labeled with digoxigenin (Roche Molecular Biochemicals, Mannheim, Germany) is shown below the gel, and arrowheads indicate the locations of the restriction fragments that were hybridized. Lanes 2–21, plasmids from transconjugants of Salmonella isolates NB04.022, SB04.003, NL04.050, SA04.028, CG04.039, SG04.039, SG04.042, SE04.006, SG04.047, SE04.005, NG04.011, NG04.016, NG04.018, NC04.001, NC04.002, NC04.003, NC04.004, and CE04.015; lanes 1 and 22, molecular marker II (Roche Molecular Biochemicals); lanes 12 and 13, a 1-kb molecular marker (Promega Co., Madison, WI, USA).

Main Article

TOP